BioNexus Gene Lab Price to Book Ratio 2019-2025 | BGLC
Historical price to book ratio values for BioNexus Gene Lab (BGLC) over the last 10 years. The current price to book ratio for BioNexus Gene Lab as of January 20, 2026 is 0.87.
| BioNexus Gene Lab Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2026-01-21 | 3.07 | 0.81 | |
| 2025-09-30 | 5.47 | $3.79 | 1.44 |
| 2025-06-30 | 3.07 | $4.19 | 0.73 |
| 2025-03-31 | 2.36 | $0.43 | 5.46 |
| 2024-12-31 | 2.80 | $4.63 | 0.60 |
| 2024-09-30 | 4.45 | $5.23 | 0.85 |
| 2024-06-30 | 4.75 | $5.40 | 0.88 |
| 2024-03-31 | 7.06 | $5.29 | 1.33 |
| 2023-12-31 | 5.30 | $0.55 | 9.70 |
| 2023-09-30 | 8.70 | $5.44 | 1.60 |
| 2023-06-30 | 26.52 | $0.34 | 77.25 |
| 2023-03-31 | 64.80 | $4.53 | 14.30 |
| 2022-12-31 | 114.00 | $4.60 | 24.76 |
| 2022-09-30 | 127.20 | $4.44 | 28.65 |
| 2022-06-30 | 136.80 | $4.71 | 29.02 |
| 2022-03-31 | 205.20 | $5.00 | 41.06 |
| 2021-12-31 | 255.60 | $5.03 | 50.77 |
| 2021-09-30 | 141.60 | $4.94 | 28.64 |
| 2021-06-30 | 138.00 | $4.78 | 28.89 |
| 2021-03-31 | 252.00 | $4.76 | 52.91 |
| 2020-12-31 | 0.00 | $4.67 | 0.00 |
| 2020-09-30 | 0.00 | $1.09 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.008B | $0.010B |
| BioNexus Gene Lab Corp. is an emerging company in the business of selling chemical raw materials principally in the Southeast Asia region and the development of biopsy tests for early diagnosis and personalized health management. BioNexus Gene Lab Corp. is based in KUALA LUMPUR, Malaysia. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $165.519B | 30.39 |
| HCA Healthcare (HCA) | United States | $105.969B | 17.54 |
| CVS Health (CVS) | United States | $101.669B | 11.69 |
| Elevance Health (ELV) | United States | $81.575B | 11.96 |
| Cencora (COR) | United States | $68.028B | 21.93 |
| Natera (NTRA) | United States | $32.485B | 0.00 |
| DiDi Global (DIDIY) | China | $22.874B | 21.13 |
| Labcorp Holdings (LH) | United States | $22.492B | 17.15 |
| Medpace Holdings (MEDP) | United States | $16.969B | 42.13 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $16.166B | 0.00 |
| Viatris (VTRS) | United States | $14.581B | 5.43 |
| BioMerieux (BMXMF) | France | $14.360B | 0.00 |
| ICON (ICLR) | Ireland | $14.259B | 14.15 |
| Solventum (SOLV) | United States | $13.695B | 13.29 |
| Revvity (RVTY) | United States | $12.686B | 23.36 |
| CochLear (CHEOY) | Australia | $11.814B | 0.00 |
| Charles River Laboratories (CRL) | United States | $10.738B | 20.68 |
| Avantor (AVTR) | United States | $8.080B | 12.34 |
| Sonic Healthcare (SKHHY) | Australia | $7.695B | 0.00 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.412B | 0.00 |
| HealthEquity (HQY) | United States | $7.177B | 26.84 |
| BrightSpring Health Services (BTSG) | United States | $6.985B | 41.65 |
| Bausch + Lomb (BLCO) | Canada | $6.053B | 39.74 |
| PACS (PACS) | United States | $5.590B | 33.99 |
| Sotera Health (SHC) | United States | $5.310B | 25.60 |
| Alignment Healthcare (ALHC) | United States | $4.550B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.719B | 21.70 |
| GeneDx Holdings (WGS) | United States | $2.881B | 50.60 |
| Concentras Parent (CON) | United States | $2.808B | 17.53 |
| Organon (OGN) | United States | $2.459B | 2.59 |
| Progyny (PGNY) | United States | $2.188B | 43.02 |
| Surgery Partners (SGRY) | United States | $2.022B | 26.05 |
| Establishment Labs Holdings (ESTA) | United States | $1.878B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.866B | 11.14 |
| Ardent Health (ARDT) | United States | $1.188B | 3.88 |
| Nutex Health (NUTX) | United States | $1.087B | 8.32 |
| Teladoc Health (TDOC) | United States | $1.077B | 0.00 |
| CareDx (CDNA) | United States | $1.039B | 16.98 |
| Omada Health (OMDA) | United States | $0.911B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.883B | 14.44 |
| InnovAge Holding (INNV) | United States | $0.806B | 0.00 |
| Embecta (EMBC) | United States | $0.728B | 4.14 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.702B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.590B | 0.00 |
| CryoPort (CYRX) | United States | $0.538B | 0.00 |
| Enhabit (EHAB) | United States | $0.528B | 23.70 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.496B | 0.00 |
| SBC Medicals (SBC) | United States | $0.440B | 8.09 |
| Agilon Health (AGL) | United States | $0.405B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.343B | 5.51 |
| Oncology Institute (TOI) | United States | $0.338B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.302B | 63.60 |
| Shoulder Innovations (SI) | United States | $0.290B | 0.00 |
| So-Young (SY) | China | $0.270B | 0.00 |
| KindlyMD (NAKA) | United States | $0.185B | 0.00 |
| Beauty Health (SKIN) | United States | $0.184B | 0.00 |
| LifeMD (LFMD) | United States | $0.171B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.134B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.125B | 0.00 |
| DocGo (DCGO) | United States | $0.079B | 0.00 |
| Biodesix (BDSX) | United States | $0.071B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.064B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.045B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.044B | 0.00 |
| Pomdoctor - (POM) | China | $0.030B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.020B | 6.24 |
| OSR Holdings (OSRH) | United States | $0.018B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.017B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.014B | 0.00 |
| Lifeward (LFWD) | United States | $0.013B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| INVO Fertility (IVF) | United States | $0.006B | 0.00 |
| Pheton Holdings (ITOC) | China | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| XWELL (XWEL) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.000B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |